The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi

Microbial Cell Factories

Volumn 2, Issue , 2003, Pages

  Joosten, Vivi ^a   Lokman, Christien ^a   van den Hondel, Cees A M J J ^a   Punt, Peter J ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; CELL ANTIBODY; FUNGUS ANTIBODY; HYBRID PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; INTRABODY; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY COMBINING SITE; ANTIBODY PRODUCTION; ANTIGEN BINDING; ASPERGILLUS AWAMORI; CANDIDA BOIDINII; CLINICAL TRIAL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; EUKARYOTE; GENE EXPRESSION SYSTEM; HANSENULA POLYMORPHA; HUMAN; IMMUNOTHERAPY; KLUYVEROMYCES; METHYLOTROPHIC BACTERIUM; MYCOLOGY; NONHUMAN; PICHIA; PICHIA METHANOLICA; PICHIA PASTORIS; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE; TRICHODERMA REESEI; YARROWIA LIPOLYTICA;

EUKARYOTA; FUNGI;

EID: 0142232284     PISSN: 14752859     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2859-2-1     Document Type: Review

References (166)

1. Köhler G and Milstein C Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497
2. Porter P, Coley J and Gani M Immunochemical criteria for successful matching of monoclonal antibodies to immunoassays of peptide hormones for assessment of pregnancy and ovulation. Prog Clin Biol Res 1988, 285:181-200
3. Van der Linden RHJ Unique characteristics of llama heavy chain antibodies. Ph.D. thesis Utrecht University. Utrecht (The Netherlands) 1999,
4. Frenken LG, Hessing JG, Van den Hondel CA and Verrips CT Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms. Res Immunol 1998, 149:589-599
5. Winter G, Griffiths AD, Hawkins RE and Hoogenboom HR Making antibodies by phage display technology. Annu Rev Immunol 1994, 12:433-455
6. Winter G and Milstein C Man-made antibodies. Nature 1991, 349:293-299
7. Padlan EA Anatomy of the antibody molecule. Mol Immunol 1994, 31:169-217
8. Better M, Chang CP, Robinson RR and Horwitz AH Escherichia coli secretion of an active chimeric antibody fragment. Science 1988, 240:1041-1043
9. v fragment in Escherichia coli. Science 1988, 240:1038-1041
10. H antibody cloned from a fusion phage library of a vaccinated melanoma patient. Proc Natl Acad Sci U S A 1996, 93:6280-6285
11. Ward ES, Gussow D, Griffiths AD, Jones PT and Winter G Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 1989, 341:544-546
12. Borrebaeck CA, Malmborg AC, Furebring C, Michaelsson A, Ward S, Danielsson L and Ohlin M Kinetic analysis of recombinant antibody-antigen interactions: relation between structural domains and antigen binding. Biotechnology (N Y) 1992, 10:697-698
13. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N and Hamers R Naturally occurring antibodies devoid of light chains. Nature 1993, 363:446-448
14. Muyldermans S and Lauwereys M Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies. J Mol Recognit 1999, 12:131-140
15. H)1 domain of the functional camel IgG2A heavy-chain antibodies. Mol Immunol 1999, 36:515-524
16. Woolven BP, Frenken LG, van der Logt P and Nicholls PJ The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation. Immunogenetics 1999, 50:98-101
17. Nguyen VK, Desmyter A and Muyldermans S Functional heavychain antibodies in Camelidae. Adv Immunol 2001, 79:261-296
18. Nguyen VK, Su C, Muyldermans S and van der Loo W Heavy-chain antibodies in Camelidae; a case of evolutionary innovation. Immunogenetics 2002, 54:39-47
19. Colcher D, Pavlinkova G, Beresford G, Booth BJ, Choudhury A and Batra SK Pharmacokinetics and biodistribution of genetically-engineered antibodies. Q J Nucl Med 1998, 42:225-241
20. Kipriyanov SM and Little M Generation of recombinant antibodies. Mol Biotechnol 1999, 12:173-201
21. Neuberger MS, Williams GT, Mitchell EB, Jouhal SS, Flanagan JG and Rabbitts TH A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature 1985, 314:268-270
22. Riechmann L, Clark M, Waldmann H and Winter G Reshaping human antibodies for therapy. Nature 1988, 332:323-327
23. Holliger P and Hoogenboom H Antibodies come back from the brink. Nat Biotechnol 1998, 16:1015-1016
24. Gura T Therapeutic antibodies: magic bullets hit the target. Nature 2002, 417:584-586
25. Pluckthun A Escherichia coli producing recombinant antibodies. Bioprocess Technol 1994, 19:233-252
26. Le Gall F, Bove JM and Garnier M Engineering of a single-chain variable-fragment (scFv) antibody specific for the stolbur phytoplasma (Mollicute) and its expression in Escherichia coli and tobacco plants. Appl Environ Microbiol 1998, 64:4566-4572
27. Zhu Z, Zapata G, Shalaby R, Snedecor B, Chen H and Carter P High level secretion of a humanized bispecific diabody from Escherichia coli. Biotechnology (N Y) 1996, 14:192-196
28. McCafferty J, Griffiths AD, Winter G and Chiswell DJ Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990, 348:552-554
29. Hoogenboom HR and Chames P Natural and designer binding sites made by phage display technology. Immunol Today 2000, 21:371-378
30. Hoogenboom HR, de Bruine AP, Hufton SE, Hoet RM, Arends JW and Roovers RC Antibody phage display technology and its applications. Immunotechnology 1998, 4:1-20
31. Marks JD, Griffiths AD, Malmqvist M, Clackson TP, Bye JM and Winter G By-passing immunization: building high affinity human antibodies by chain shuffling. Biotechnology (N Y) 1992, 10:779-783
32. v fragments. J Mol Biol 2001, 305:989-1010
33. v s. Faseb J 1995, 9:73-80
34. Verma R, Boleti E and George AJ Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. J Immunol Methods 1998, 216:165-181
35. Huston JS, McCartney J, Tai MS, Mottola-Hartshorn C, Jin D, Warren F, Keck P and Oppermann H Medical applications of single-chain antibodies. Int Rev Immunol 1993, 10:195-217
36. Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, Lee T, Pope SH, Riordan GS and Whitlow M Single-chain antigen-binding proteins. Science 1988, 242:423-426
37. Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotny J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E and Crea R Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A 1988, 85:5879-5883
38. v-fragments. Biochemistry 1990, 29:1362-1367
39. v derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand. J Biol Chem 1996, 271:5338-5346
40. v with reduced aggregation and enhanced proteolytic stability. Protein Eng 1993, 6:989-995
41. Brinkmann U, Reiter Y, Jung SH, Lee B and Pastan I A recombinant immunotoxin containing a disulfide-stabilized Fv fragment. Proc Natl Acad Sci U S A 1993, 90:7538-7542
42. v fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions. Biochemistry 1994, 33:5451-5459
43. v fragments. Nat Biotechnol 1996, 14:1239-1245
44. L domains dictates precisely the transition between diabodies and triabodies. Protein Eng 1999, 12:597-604
45. Hudson PJ and Kortt AA High avidity scFv multimers; diabodies and triabodies. J Immunol Methods 1999, 231:177-189
46. Cao Y and Suresh MR Bispecific antibodies as novel bioconjugates. Bioconjug Chem 1998, 9:635-644
47. Kriangkum J, Xu B, Nagata LP, Fulton RE and Suresh MR Bispecific and bifunctional single chain recombinant antibodies. Biomol Eng 2001, 18:31-40
48. . Sheriff S and Constantine KL Redefining the minimal antigen-binding fragment. Nat Struct Biol 1996, 3:733-736
49. Muyldermans S Single domain camel antibodies: current status. J Biotechnol 2001, 74:277-302
50. HH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta 1999, 1431:37-46
51. Lauwereys M, Arbabi Ghahroudi M, Desmyter A, Kinne J, Holzer W, De Genst E, Wyns L and Muyldermans S Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. Embo J 1998, 17:3512-3520
52. Ghahroudi M, Desmyter A, Wyns L, Hamers R and Muyldermans S Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 1997, 414:521-526
53. Knarr G, Gething MJ, Modrow S and Buchner J BiP binding sequences in antibodies. J Biol Chem 1995, 270:27589-27594
54. van der Linden RH, de Geus B, Frenken GJ, Peters H and Verrips CT Improved production and function of llama heavy chain antibody fragments by molecular evolution. J Biotechnol 2000, 80:261-270
55. H domains. FEBS Lett 1994, 339:285-290
56. H domains with improved protein stability. Protein Eng 1996, 9:531-537
57. Tanha J, Xu P, Chen Z, Ni F, Kaplan H, Narang SA and MacKenzie CR Optimal design features of camelized human single-domain antibody libraries. J Biol Chem 2001, 276:24774-24780
58. H domains. J Immunol Methods 1999, 231:25-38
59. Neuberger MS, Williams GT and Fox RO Recombinant antibodies possessing novel effector functions. Nature 1984, 312:604-608
60. Hazra DK, Britton KE, Lahiri VL, Gupta AK, Khanna P and Saran S Immunotechnological trends in radioimmunotargeting: from 'Magic bullet' to 'smart bomb'. Nucl Med Commun 1995, 16:66-75
61. Hudson PJ Recombinant antibody constructs in cancer therapy. Curr Opin Immunol 1999, 11:548-557
62. von Mehren M and Weiner LM Monoclonal antibody-based therapy. Curr Opin Oncol 1996, 8:493-498
63. v and comparison with other immunoglobulin forms. Cancer Res 1992, 52:3402-3408
64. Cortez-Retamozo V, Lauwereys M, Hassanzadeh Gh G, Gobert M, Conrath K, Muyldermans S, De Baetselier P and Revets H Efficient tumor targeting by single-domain antibody fragments of camels. Int J Cancer 2002, 98:456-462
65. Maynard JA, Maassen CB, Leppla SH, Brasky K, Patterson JL, Iverson BL and Georgiou G Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat Biotechnol 2002, 20:597-601
66. Marasco WA Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy. Immunotechnology 1995, 1:1-19
67. Spooner RA, Murray S, Rowlinson-Busza G, Deonarain MP, Chu A and Epenetos AA Genetically engineered antibodies for diagnostic pathology. Hum Pathol 1994, 25:606-614
68. Boleti E, Deonarain MP, Spooner RA, Smith AJ, Epenetos AA and George AJ Construction, expression and characterisation of a single chain anti-tumour antibody (scFv)-IL-2 fusion protein. Ann Oncol 1995, 6:945-947
69. Conrath K, Lauwereys M, Wyns L and Muyldermans S Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J Biol Chem 2001, 276:7346-7350
70. Muruganandam A, Tanha J, Narang S and Stanimirovic D Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. Faseb J 2002, 16:240-242
71. Vu KB, Ghahroudi MA, Wyns L and Muyldermans S Comparison of llama VH sequences from conventional and heavy chain antibodies. Mol Immunol 1997, 34:1121-1131
72. Harmsen MM, Ruuls RC, Nijman IJ, Niewold TA, Frenken LG and de Geus B Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features. Mol Immuno 2000, 37:579-590
73. H antibody fragment in complex with lysozyme. Nat Struct Biol 1996, 3:803-811
74. Transue TR, De Genst E, Ghahroudi MA, Wyns L and Muyldermans S Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate. Proteins 1998, 32:515-522
75. Conrath KE, Lauwereys M, Galleni M, Matagne A, Frere JM, Kinne J, Wyns L and Muyldermans S Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae. Antimicrob Agents Chemother 2001, 45:2807-2812
76. HH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology. J Biol Chem 2002, 277:23645-23650
77. Ledeboer AM, Bezemer S, de Hiaard JJ, Schaffers IM, Verrips CT, van Vliet C, Dusterhoft EM, Zoon P, Moineau S and Frenken LG Preventing phage lysis of Lactococcus lactis in cheese production using a neutralizing heavy-chain antibody fragment from llama. J Dairy Sci 2002, 85:1376-1382
78. Graham BM, Porter AJ and Harris WJ Cloning, expression and characterization of a single-chain antibody fragment to the herbicide paraquat. J Chem Technol Biotechnol 1995, 63:279-289
79. Got PA and Scherrmann JM Stereoselectivity of antibodies for the bioanalysis of chiral drugs. Pharm Res 1997, 14:1516-1523
80. Janda KD, Lo LC, Lo CH, Sim MM, Wang R, Wong CH and Lerner RA Chemical selection for catalysis in combinatorial antibody libraries. Science 1997, 275:945-948
81. Wade H and Scanlan TS The structural and functional basis of antibody catalysis. Annu Rev Biophys Biomol Struct 1997, 26:461-493
82. Beggs T, Hammond K and Klugkist J Oral compositions. WO 95/01155 1995,
83. Hill KJ, Kaszuba M, Creeth JE and Jones MN Reactive liposomes encapsulating a glucose oxidase-peroxidase system with antibacterial activity. Biochim Biophys Acta 1997, 1326:37-46
84. Lis M and Kuramitsu HK Galactose oxidase-glucan binding domain fusion proteins as targeting inhibitors of dental plaque bacteria. Antimicrob Agents Chemother 1997, 41:999-1003
85. Hayes ML A lactate oxidase salivary peroxidase thiocyanate antibacterial enzyme system. Microb Ecol Health Dis 1996, 9:321-328
86. Harrison JS and Keshavarz-Moore E Production of antibody fragments in Escherichia coli. Ann N Y Acad Sci 1996, 782:143-158
87. Skerra A Bacterial expression of immunoglobulin fragments. Curr Opin Immunol 1993, 5:256-262
88. Kortt AA, Malby RL, Caldwell JB, Gruen LC, Ivancic N, Lawrence MC, Howlett GJ, Webster RG, Hudson PJ and Colman PM Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex. Eur J Biochem1994, 221:151-157
89. v antibodies for clinical applications using metal chelate chromatography. J Immunol Methods 1995, 179:105-116
90. Jurado P, Ritz D, Beckwith J, de Lorenzo V and Fernandez LA Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli. J Mol Biol 2002, 320:1-10
91. Kruger C, Hu Y, Pan Q, Marcotte H, Hultberg A, Delwar D, Van Dalen PJ, Pouwels PH, Leer RJ, Kelly CG, Van Dollenweerd C, Ma JK and Hammarstrom L In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol 2002, 20:702-706
92. Conrad U and Fiedler U Compartment-specific accumulation of recombinant immunoglobulins in plant cells: an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Mol Biol 1998, 38:101-109
93. Peeters K, De Wilde C, De Jaeger G, Angenon G and Depicker A Production of antibodies and antibody fragments in plants. Vaccine 2001, 19:2756-2761
94. Stöger E, Vaquero C, Torres E, Sack M, Nicholson L, Drossard J, Williams S, Keen D, Perrin Y, Christou P and Fischer R Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Mol Biol 2000, 42:583-590
95. v antibody in transgenic Arabidopsis plants. Appl Environ Microbiol 2000, 66:3499-3505
96. De Jaeger G, De Wilde C, Eeckhout D, Fiers E and Depicker A The plantibody approach: expression of antibody genes in plants to modulate plant metabolism or to obtain pathogen resistance. Plant Mol Biol 2000, 43:419-428
97. Ziegler A and Torrance L Applications of recombinant antibodies in plant pathology. Mol Plant Pathol 2002, 3:401-407
98. Gellissen G Heterologous protein production in methylotrophic yeasts. Appl Microbiol Biotechnol 2000, 54:741-750
99. Cregg JM, Vedvick TS and Raschke WC Recent advances in the expression of foreign genes in Pichia pastoris. Biotechnology (N Y) 1993, 11:905-910
100. Faber KN, Harder W, Ab G and Veenhuis M Review: methylotrophic yeasts as factories for the production of foreign proteins. Yeast 1995, 11:1331-1344
101. Fischer R, Drossard J, Emans N, Commandeur U and Hellwig S Towards molecular farming in the future: Pichia pastoris-based production of single-chain antibody fragments. Biotechnol Appl Biochem 1999, 30:117-120
102. Cregg JM, Cereghino JL, Shi J and Higgins DR Recombinant protein expression in Pichia pastoris. Mol Biotechnol 2000, 16:23-52
103. Ridder R, Schmitz R, Legay F and Gram H Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris. Biotechnology (N Y) 1995, 13:255-260
104. c Fragment of the Human IgG1 Tag: Construction,Pichia pastoris Expression and Antigen Binding Characterization. J Biochem (Tokyo) 2000, 128:891-895
105. Pennell CA and Eldin P In vitro production of recombinant antibody fragments in Pichia pastoris. Res Immunol 1998, 149:599-603
106. v fragments by Pichia pastoris. J Immunol Methods 1997, 201:67-75
107. v antibody fragment in the yeast Pichia pastoris. J Biotechnol 2000, 76:157-163
108. Cupit PM, Whyte JA, Porter AJ, Browne MJ, Holmes SD, Harris WJ and Cunningham C Cloning and expression of single chain antibody fragments in Escherichia coli and Pichia pastoris. Lett Appl Microbiol 1999, 29:273-277
109. Wood CR, Boss MA, Kenten JH, Calvert JE, Roberts NA and Emtage JS The synthesis and in vivo assembly of functional antibodies in yeast. Nature 1985, 314:446-449
110. Horwitz AH, Chang CP, Better M, Hellstrom KE and Robinson RR Secretion of functional antibody and Fab fragment from yeast cells. Proc Natl Acad Sci U S A 1988, 85:8678-8682
111. Davis GT, Bedzyk WD, Voss EW and Jacobs TW Single chain antibody (SCA) encoding genes: one-step construction and expression in eukaryotic cells. Biotechnology (N Y) 1991, 9:165-169
112. Swennen D, Paul MF, Vernis L, Beckerich JM, Fournier A and Gaillardin C Secretion of active anti-Ras single-chain Fv antibody by the yeasts Yarrowia lipolytica and Kluyveromyces lactis. Microbiology 2002, 148:41-50
113. Radzio R and Kuck U Synthesis of biotechnologically relevant heterologous proteins in filamentous fungi. Process-biochem 1997, 32:529-539
114. Punt PJ, van Biezen N, Conesa A, Albers A, Mangnus J and van den Hondel C Filamentous fungi as cell factories for heterologous protein production. Trends Biotechnol 2002, 20:200-206
115. van den Hondel CAJJM, Punt PJ and van Gorcum RFM Heterologous gene expression in filamentous fungi. In: More genetic manipulations of filamentous fungi (Edited by: Bennet JW, Lasure LL) Orlando, Academic Press 1991, 396-428
116. Verdoes JC, Punt PJ and van den Hondel CAMJJ Molecular genetic strain improvement for the overproduction of fungal proteins by filamentous fungi. Appl Microbiol Biotechnol 1995, 43:195-205
117. Gouka RJ, Punt PJ and van den Hondel CAMJJ Efficient production of secreted proteins by Aspergillus: progress, limitations and prospects. Appl Microbiol Biotechnol 1997, 47:1-11
118. Ward M, Wilson LJ, Kodama KH, Rey MW and Berka RM Improved production of chymosin in Aspergillus by expression as a glucoamylase-chymosin fusion. Biotechnology (N Y) 1990, 8:435-440
119. Archer DB, Jeenes DJ and Mackenzie DA Strategies for improving heterologous protein production from filamentous fungi. Antonie Van Leeuwenhoek 1994, 65:245-250
120. Durand H, Clanet M and Tiraby G Genetic improvement of Trichoderma reesei for large scale cellulase production. Enzyme Microb Technol 1988, 6:341-346
121. Keranen S and Penttila M Production of recombinant proteins in the filamentous fungus Trichoderma reesei. Curr Opin Biotechnol 1995, 6:534-537
122. Nevalainen H, Suominen P and Taimisto K On the safety of Trichoderma reesei. J Biotechnol 1994, 37:193-200
123. Nyyssönen E, Penttila M, Harkki A, Saloheimo A, Knowles JK and Keranen S Efficient production of antibody fragments by the filamentous fungus Trichoderma reesei. Biotechnology (N Y) 1993, 11:591-595
124. Nyyssonen E, Keranen K, Penttila M, Takkinen K and Knowles JKC Immunoglobulin production by Trichoderma. World Patent Application WO 92/01797 1992,
125. Hessing JGM, van Gorcom RFM, Verbakel JMA, Musters W, Frenken LGJ, van den Hondel CAMJJ and Verrips CT Process for producing fusion proteins comprising scFv fragments by a transformed mould. World Patent Application WO 94/29457 1994,
126. Hamers R, Hamers-Casterman C, Muyldermans S, Frenken LGJ and Verrips CT Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of Camelidae. World Patent Application WO 94/25591 1994,
127. Gouka RJ, Hessing JG, Punt PJ, Stam H, Musters W and van den Hondel CAMJJ An expression system based on the promoter region of the Aspergillus awamori 1,4-beta-endoxylanase A gene. Appl Microbiol Biotechnol 1996, 46:28-35
128. v antibody fragments produced in Saccharomyces cerevisiae accumulate in the endoplasmic reticulum and the vacuole. Biological membranes: structure biogenesis and dynamics (Edited by: NATO ASI Series) Springer-Verlag Berlin, Heidelberg 1994, H82:223-236
129. Shusta EV, Raines-R T, Pluckthun A and Wittrup-K D Increasing the secretory capacity of Saccharomyces cerevisiae for production of single chain antibody fragments. Nat Biotechnol 1998, 16:773-777
130. Kauffman KJ, Pridgen EM, Doyle FJ, Dhurjati PS and Robinson AS Decreased protein expression and intermittent recoveries in BiP levels result from cellular stress during heterologous protein expression in Saccharomyces cerevisiae. Biotechnol Prog 2002, 18:942-950
131. Punt PJ, van Gemeren IA, Drint-Kuijvenhoven J, Hessing JG, van Muijlwijk-Harteveld GM, Beijersbergen A, Verrips CT and van den Hondel CA Analysis of the role of the gene bipA, encoding the major endoplasmic reticulum chaperone protein in the secretion of homologous and heterologous proteins in black Aspergilli. Appl Microbiol Biotechnol 1998, 50:447-454
132. Sotiriadis A, Keshavarz T and Keshavarz-Moore E Factors Affecting the Production of a Single-Chain Antibody Fragment by Aspergillus awamori in a Stirred Tank Reactor. Biotechnol Prog 2001, 17:618-623
133. Sagt CM, Muller WH, Boonstra J, Verkleij AJ and Verrips CT Impaired secretion of a hydrophobic cutinase by Saccharomyces cerevisiae correlates with an increased association with immunoglobulin heavy-chain binding protein (BiP). Appl Environ Microbiol 1998, 64:316-324
134. Frenken LG, van der Linden RH, Hermans PW, Bos JW, Ruuls RC, de Geus B and Verrips CT Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol 2000, 78:11-21
135. HH antibody fragments by Saccharomyces cerevisiae. Enzyme Microb Technol 2002, 30:273-278
136. Verhoeyen ME, van der Logt CP, Beggs TS and Davis PJ Antibody fragments for controlled delivery of therapeutic agents. Biochem Soc Trans 1995, 23:1067-1073
137. Akimoto K, Shinmen Y, Sumida M, Asami S, Amachi T, Yoshizumi H, Saeki Y, Shimizu S and Yamada H Luminol chemiluminescence reaction catalyzed by a microbial peroxidase. Anal Biochem 1990, 189:182-185
138. Fukuyama K, Kunishima N, Amada F, Kubota T and Matsubara H Crystal structures of cyanide- and triiodide-bound forms of Arthromyces ramosus peroxidase at different pH values. Perturbations of active site residues and their implication in enzyme catalysis. J Biol Chem 1995, 270:21884-21892
139. Kjalke M, Andersen MB, Schneider P, Christensen B, Schulein M and Welinder KG Comparison of structure and activities of peroxidases from Coprinus cinereus, Coprinus macrorhizus and Arthromyces ramosus. Biochim Biophys Acta 1992, 1120:248-256
140. Borrebaeck CA Antibodies in diagnostics - from immunoassays to protein chips. Immunol Today 2000, 21:379-382
141. Holt LJ, Enever C, de Wildt RM and Tomlinson IM The use of recombinant antibodies in proteomics. Curr Opin Biotechnol 2000, 11:445-449
142. Maras M, van Die I, Contreras R and van den Hondel CA Filamentous fungi as production organisms for glycoproteins of biomedical interest. Glycoconj J 1999, 16:99-107
143. Wu XC, Ng SC, Near RI and Wong SL Efficient production of a functional single-chain antidigoxin antibody via an engineered Bacillus subtilis expression-secretion system. Biotechnology (N Y) 1993, 11:71-76
144. Wu SC, Yeung JC, Duan Y, Ye R, Szarka SJ, Habibi HR and Wong SL Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: effects of molecular chaperones and a wall-bound protease on antibody fragment production. Appl Environ Microbiol 2002, 68:3261-3269
145. Binnie C, Cossar JD and Stewart DI Heterologous biopharmaceutical protein expression in Streptomyces. Trends Biotechnol 1997, 15:315-320
146. Ueda Y, Tsumoto K, Watanabe K and Kumagai I Synthesis and expression of a DNA encoding the Fv domain of an anti-lysozyme monoclonal antibody, HyHEL10, in Streptomyces lividans. Gene 1993, 129:129-134
147. Pschorr J, Bieseler B and Fritz HJ Production of the immunoglobulin variable domain REIv via a fusion protein synthesized and secreted by Staphylococcus carnosus. Biol Chem Hoppe Seyler 1994, 375:271-280
148. Kujau MJ, Hoischen C, Riesenberg D and Gumpert J Expression and secretion of functional miniantibodies McPC603scFvDhlx in cell-wall-less L-form strains of Proteus mirabilis and Escherichia coli: a comparison of the synthesis capacities of L-form strains with an E. coli producer strain. Appl Microbiol Biotechnol 1998, 49:51-58
149. v) antibodies: secretion in L-form cells of Proteus mirabilis leads to active product and overcomes the limitations of periplasmic expression in Escherichia coli. Appl Environ Microbiol 1998, 64:4862-4869
150. Neuberger MS Making novel antibodies by expressing transfected immunoglobulin genes. Trends Biochem Sci 1985, 9:347-349
151. v fragments. Biochem J 1993, 290:723-729
152. v fragment in myeloma cells. J Mol Biol 1988, 203:825-828
153. v) antibody proteins and their C-terminal fusions with interleukin-2 and other effector domains. Biotechnology (N Y) 1994, 12:890-897
154. v molecules. J Biol Chem 1994, 269:26267-26273
155. Ailor E and Betenbaugh MJ Modifying secretion and post-translational processing in insect cells. Curr Opin Biotechnol 1999, 10:142-145
156. Bei R, Schlom J and Kashmiri SV Baculovirus expression of a functional single-chain immunoglobulin and its IL-2 fusion protein. J Immunol Methods 1995, 186:245-255
157. Carayannopoulos L, Max EE and Capra JD Recombinant human IgA expressed in insect cells. Proc Natl Acad Sci U S A 1994, 91:8348-8352
158. Hasemann CA and Capra JD High-level production of a functional immunoglobulin heterodimer in a baculovirus expression system. Proc Natl Acad Sci U S A 1990, 87:3942-3946
159. v antibodies. J Immunol Methods 1996, 195:93-101
160. v antibody fragments in stably transfected insect cell lines. J Immunol Methods 1998, 212:149-160
161. Hiatt A, Cafferkey R and Bowdish K Production of antibodies in transgenic plants. Nature 1989, 342:76-78
162. Fischer R, Vaquero-Martin C, Sack M, Drossard J, Emans N and Commandeur U Towards molecular farming in the future: transient protein expression in plants. Biotechnol Appl Biochem 1999, 30:113-116
163. Kuroiwa Y, Kasinathan P, Choi YJ, Naeem R, Tomizuka K, Sullivan EJ, Knott JG, Duteau A, Goldsby RA, Osborne BA, Ishida I and Robl JM Cloned transchromosomic calves producing human immunoglobulin. Nat Biotechnol 2002, 20:889-894
164. Little M, Kipriyanov SM, Le Gall F and Moldenhauer G Of mice and men: hybridoma and recombinant antibodies. Immunol Today 2000, 21:364-370
165. Pollock DP, Kutzko JP, Birck-Wilson E, Williams JL, Echelard Y and Meade HM Transgenic milk as a method for the production of recombinant antibodies. J Immunol Methods 1999, 231:147-157
166. Young MW, Meade H, Curling JM, Ziomek CA and Harvey M Production of recombinant antibodies in the milk of transgenic animals. Res Immunol 1998, 149:609-610